These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 29127006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
    Son M, Oh S, Park H, Ahn H, Choi J, Kim H, Lee HS, Lee S, Park HJ, Kim SU, Lee B, Byun K.
    Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.
    Park MJ, Lee SH, Moon SJ, Lee JA, Lee EJ, Kim EK, Park JS, Lee J, Min JK, Kim SJ, Park SH, Cho ML.
    Sci Rep; 2016 Nov 02; 6():35933. PubMed ID: 27804999
    [Abstract] [Full Text] [Related]

  • 4. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD.
    Exp Neurol; 2001 Sep 02; 171(1):29-45. PubMed ID: 11520119
    [Abstract] [Full Text] [Related]

  • 5. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K.
    Mol Cell Biochem; 2019 Sep 02; 459(1-2):95-112. PubMed ID: 31079281
    [Abstract] [Full Text] [Related]

  • 6. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
    Wang J, Wang H, Shi J, Ding Y.
    Int J Clin Exp Pathol; 2015 Sep 02; 8(10):12028-40. PubMed ID: 26722388
    [Abstract] [Full Text] [Related]

  • 7. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF, Yan SD, Stern DM, Walker DG.
    Curr Drug Targets CNS Neurol Disord; 2005 Jun 02; 4(3):249-66. PubMed ID: 15975028
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease.
    Fuller KNZ, Miranda ER, Thyfault JP, Morris JK, Haus JM.
    Mediators Inflamm; 2018 Jun 02; 2018():2061376. PubMed ID: 29681765
    [Abstract] [Full Text] [Related]

  • 13. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
    Ataç ZS, Alaylıoğlu M, Dursun E, Gezen-Ak D, Yılmazer S, Gürvit H.
    J Clin Neurosci; 2019 Jan 02; 59():197-201. PubMed ID: 30389362
    [Abstract] [Full Text] [Related]

  • 14. Role of RAGE in Alzheimer's Disease.
    Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M, Chang L, Yan LJ, Zhao B.
    Cell Mol Neurobiol; 2016 May 02; 36(4):483-95. PubMed ID: 26175217
    [Abstract] [Full Text] [Related]

  • 15. Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.
    Byun K, Bayarsaikhan E, Kim D, Kim CY, Mook-Jung I, Paek SH, Kim SU, Yamamoto T, Won MH, Song BJ, Park YM, Lee B.
    PLoS One; 2012 May 02; 7(5):e37917. PubMed ID: 22662249
    [Abstract] [Full Text] [Related]

  • 16. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
    Kuhla A, Ludwig SC, Kuhla B, Münch G, Vollmar B.
    Neurobiol Aging; 2015 Feb 02; 36(2):753-61. PubMed ID: 25448604
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
    Lee JK, Jin HK, Bae JS.
    Neurosci Lett; 2009 Jan 30; 450(2):136-41. PubMed ID: 19084047
    [Abstract] [Full Text] [Related]

  • 18. Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
    Kim DY, Choi SH, Lee JS, Kim HJ, Kim HN, Lee JE, Shin JY, Lee PH.
    J Alzheimers Dis; 2020 Jan 30; 76(4):1281-1296. PubMed ID: 32597802
    [Abstract] [Full Text] [Related]

  • 19. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques.
    Kim JY, Kim DH, Kim JH, Lee D, Jeon HB, Kwon SJ, Kim SM, Yoo YJ, Lee EH, Choi SJ, Seo SW, Lee JI, Na DL, Yang YS, Oh W, Chang JW.
    Cell Death Differ; 2012 Apr 30; 19(4):680-91. PubMed ID: 22015609
    [Abstract] [Full Text] [Related]

  • 20. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
    Son KH, Son M, Ahn H, Oh S, Yum Y, Choi CH, Park KY, Byun K.
    Biochem Biophys Res Commun; 2016 Aug 19; 477(2):271-6. PubMed ID: 27301641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.